The GDM conference has been postponed because of Hurricane Sandy. The conference will be rescheduled for March 4–6, 2013.
Experts will examine available scientific evidence and draft a consensus statement on how to diagnose GDM
GDM is a condition that occurs when a pregnant woman who did not have previously diagnosed diabetes has high blood glucose levels. It is among the most common disorders of pregnancy, affecting between 2% and 10% of pregnancies in the United States, according to the Centers for Disease Control and Prevention (CDC).
GDM increases risk of pregnancy complications for both the mother and baby, including preeclampsia (high blood pressure, excess protein in the urine), cesarean delivery, macrosomia (large birth weight), shoulder dystocia (when a baby's shoulders get stuck during delivery), and birth injuries. In addition, the newborn may have hypoglycemia (low blood sugar) and jaundice.
GDM also poses long-term health risks to both mother and baby. Women who had GDM are at risk for developing type 2 diabetes. Current statistics from the CDC suggest that up to one-half of women who had GDM will develop type 2 diabetes. Infants whose mothers had GDM may also be at higher risk for health conditions later in life, including overweight/obesity and type 2 diabetes.
Understanding GDM is an active area of research for the NICHD. Select a link below to learn more about the conference and the Institute’s efforts related GDM.
NIH Consensus Development Conference on GDMOther NICHD Activities Related to GDMMore Information
To better understand the best method to diagnose gestational diabetes, the NICHD and the NIH Office of Disease Prevention are co-sponsoring a 3-day consensus development conference titled Diagnosing Gestational Diabetes Mellitus from March 4–6, 2013.
At this conference, independent experts will use the collected evidence to address the following key questions:
Consensus conferences are distinctive because the resulting consensus statement comes from an independent and unbiased expert panel. The 12 to 16 panel members have no conflicts of interest, or financial or career (research) interests related to the topic. They are experts in their own fields, reflect a variety of perspectives, and are knowledgeable on the subject.
A draft statement will be disseminated to attendees on the last day of the conference for open discussion. Following this public comment period, the panel issues its consensus statement, which is an independent report of the panel and not a policy statement of NIH. The final consensus statement from the conference will be widely distributed to health care providers, policy makers, patients, researchers, members of the public, and the media.
Examples of NICHD activities in this area include (but are not limited to) the following:
Originally posted: October 26, 2012Updated: November 28, 2012
All NICHD Spotlights
All related topics
All related organizational units